Comparing the patients’ characteristics between the cholangiocarcinoma and pancreatic cancer group, these two groups were similar in the male-to-female ratio, level of serum total bilirubin, CEA, alkaline phosphatase, and number of biopsy specimens (Table 2). This evidence concerns the gene CEACAM5 and pancreatic neoplasm.